Telehealth providers in Colorado

Verified telehealth providers serving Colorado

Telehealth prescribing rules in Colorado

C.R.S. 12-240-107 includes telemedicine in the definition of the practice of medicine, and the practice occurs where the patient is located, so the prescriber needs a Colorado license (Colorado participates in the Interstate Medical Licensure Compact, which is one route to that license). The Colorado Medical Board's published policies (Policy 40-03 on the provider-patient relationship, revised 2015, and Policy 40-27, guidelines for the appropriate use of telehealth technologies, issued 2015 and revised December 18, 2020 and August 19, 2021) say a provider-patient relationship may be established through telehealth whether or not there has been an in-person encounter, as long as it conforms to generally accepted standards of practice, the provider verifies the patient's identity and location, discloses the provider's identity and credentials, and obtains appropriate informed consent. Policy 40-27 defines telehealth to include store-and-forward transfers, requires an appropriate medical evaluation and review of relevant clinical history before any prescription, holds online prescribing to in-person standards, and states that treatment, including a prescription, based solely on an online questionnaire does not constitute an acceptable standard of care. The policies do not require a real-time video visit, so a first non-controlled prescription may follow an asynchronous evaluation that meets that standard, but a questionnaire-only intake does not. [2] [3] [4] [14]

Compounded GLP-1 access in Colorado

Colorado patients using a telehealth GLP-1 program should confirm the prescriber holds a Colorado license and that an out-of-state dispensing pharmacy appears as a registered nonresident prescription drug outlet. The Board of Pharmacy rules (3 CCR 719-1) contain no GLP-1-specific provision, and a 2026 bill to regulate the marketing and distribution of compounded GLP-1 weight-loss medication (SB26-066) was postponed indefinitely in a House committee on May 5, 2026 and did not become law, so federal compounding limits and the general Colorado rules apply. [5] [7] [8] [11] [12]

Research use only sellers in Colorado

Only registered prescription drug outlets, including registered nonresident outlets, may dispense prescription drugs to Colorado patients. "Research use only" peptides sold for human injection are unapproved new drugs under federal law regardless of labeling and are not dispensed by a pharmacist. Colorado law also bars the sale directly: C.R.S. 12-280-131 says no person shall sell, deliver, offer for sale, hold for sale, or give away any new drug not authorized to move in interstate commerce under federal law, with an exception only for drugs intended solely for investigational use by qualified experts and plainly labeled for investigational use only. [5] [6] [13]